Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease psoriasis
Symptom C0042373|vascular disease
Sentences 17
PubMedID- 24161194 An interdisciplinary approach is needed to find the necessary steps beyond classic risk reduction and detection of early cardiovascular disease in patients with psoriasis, as well as to develop a cardiovascular disease preventive regimen.
PubMedID- 26422385 psoriasis is associated with increased cardiovascular disease (cvd) in adults, but the risk profile of children with psoriasis remains to be fully characterized.
PubMedID- 25752901 Objectives: an increased risk for cardiovascular disease with psoriasis has been reported.
PubMedID- 26300652 There is overwhelming evidence on the higher risk of cardiovascular diseases in patients with psoriasis as a result of hyperlipidemia, which is more common in these patients.
PubMedID- 24599540 A combinational therapy for patients with severe psoriasis associated with cardiovascular disease.
PubMedID- 24320841 psoriasis is associated with cardiovascular diseases (cvd).
PubMedID- 22963528 Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a danish real-world cohort study.
PubMedID- 25291969 psoriasis with cardio- and cerebrovascular disease showed significantly higher crp levels compared with those without the diseases.
PubMedID- 25622660 A further evidence of a link between, obesity, inflammation and cardiovascular diseases in patients with psoriasis is provided by several studies reporting a correlation between pasi score and increased of c-reactive protein (crp) levels , an acute phase protein significantly associated with obesity, representing the most sensitive markers of inflammation and an independent risk for cardiovascular disease.
PubMedID- 23636854 Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris.
PubMedID- 24238156 Background: the possible connection between psoriasis with cardiovascular disease and associated risk factors has been implied, but inconsistent results have been reported.
PubMedID- 22500772 It has been proved that psoriasis is associated with risk of cardiovascular disease, diabetes, overweight/obesity and depression .
PubMedID- 22161801 Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis.
PubMedID- 24860744 increased mortality from cardiovascular disease in patients with severe psoriasis has been documented and psoriasis may be an independent risk factor for myocardial infarction, especially in young patients.
PubMedID- 25896794 Therefore, while tnf-alpha inhibitors were shown to reduce development of cardiovascular disease in patients with psoriasis , no evidence regarding such an effect is available in pemphigus.
PubMedID- 23058814 Background: psoriasis has been associated with cardiovascular diseases, but its relationship to markers of subclinical atherosclerosis has not been fully elucidated.
PubMedID- 24504802 Hypercholesterolemia is a major risk factor for cardiovascular disease, and patients with psoriasis or psoriatic arthritis (psa) have been shown to have elevated cholesterol levels.

Page: 1